A549-Dual™ KO-RIG-I Cells

Product Unit size Cat. code Docs. Qty. Price

A549-Dual™ KO-RIG-I Cells

RIG-I knockout NF-kB-SEAP & IRF-Lucia reporter lung carcinoma cells

Show product

3-7 x 10e6 cells


RIG-I knockout NF-kB-SEAP & IRF-Lucia Reporter Cell Line

A549-Dual™ KO-RIG-I cells were generated from A549-Dual™ cells through the stable knockout of the RIG-I gene. They are adherent epithelial cells derived from the human A549 lung carcinoma cell line by stable integration of two inducible reporter constructs. The A549 cell line, a cellular model for asthma and respiratory infections, expresses many pattern recognition receptors (PRRs), including RIG-I [1, 2], and the Toll-like receptors (TLRs) TLR2 [3], TLR3 and TLR5 but not TLR4 [3].

A549-Dual™ KO-RIG-I and A549-Dual™ cells express a secreted embryonic alkaline phosphatase (SEAP) reporter gene under the control of the IFN-β minimal promoter fused to five NF-κB binding sites. They also express the secreted Lucia luciferase reporter gene under the control of an ISG54 minimal promoter in conjunction with five IFN-stimulated response elements. As a result, they allow to simultaneously study the NF-kB pathway, by assessing the activity of SEAP, and the interferon regulatory factor (IRF) pathway, by monitoring the activity of Lucia luciferase. Both reporter proteins are readily measurable in the cell culture supernatant when using QUANTI-Blue™ Solution, a SEAP detection reagent, and QUANTI‑Luc™ 4 Lucia/Gaussia, a Lucia and Gaussia luciferase detection reagent.

A549-Dual™ KO-RIG-I cells are resistant to blasticidin and Zeocin®.



1. Kolokoltsova OA. et al., 2014. RIG-I enhanced interferon independent apoptosis upon Junin virus infection. PLoS One. 9:e99610.
2. Hagmann CA. et al., 2013. RIG-I detects triphosphorylated RNA of Listeria monocytogenes during infection in non-immune cells. PLoS One. 8:e62872.
3. Slevogt H. et al., 2007. Moraxella catarrhalis is internalized in respiratory epithelial cells by a trigger-like mechanism and initiates a TLR2- and partly NOD1-dependent inflammatory immune response. Cell Microbiol. 9(3):694-707.


Validation of RIG-I knockout by Western blot (Wes™)
Validation of RIG-I knockout by Western blot (Wes™)

Analysis of lysates from the A549-Dual™ (WT) and A549-Dual™ KO-RIG-I (KO) cells using Anti-RIG-I, followed by an HRP-conjugated anti-rabbit secondary antibody. The arrow indicates the expected band for the RIG-I protein (102 KDa).


A549-Dual™ (parental cell line) and A549-Dual™ KO-RIG-I cells were stimulated with hIFN-α (1 x 104 U/ml), 5’ppp-dsRNA /LyoVec™ (1 μg/ml), inactivated NDV (1.86 x 105 U/ml), poly(I:C) HMW/LyoVec™ (100 ng/ml), poly(dA:dT)/LyoVec™ (10 ng/ml), HSV60/LyoVec™ (1 μg/ml), 2’3’-cGAMP (10 μg/ ml) and poly(I:C) HMW (1 μg/ml).

After a 24h incubation, IRF activation was determined by measuring the relative light units (RLUs) in a luminometer using QUANTI-Luc™, a Lucia luciferase detection reagent.


A549-Dual™ and A549-Dual™ KO-RIG-I cells were incubated with human TNF-α (1 ng/ml), 5’ppp-dsRNA /LyoVec™ (1 μg/ml), NDV (5 x 106 U/ml), poly(I:C) HMW/LyoVec™ (100 ng/ml), poly(dA:dT)/LyoVec™ (1 μg/ml), poly(dA:dT)/LyoVec™ (100 ng/ml), HSV60/LyoVec™ (1 μg/ml), 2’3’-cGAMP (10 μg/ml) and poly(I:C) HMW (1 μg/ml).

After a 24h incubation, NF-kB activation was determined using QUANTI-Blue™, a SEAP detection reagent, and by reading the optical density (OD) at 655 nm.

Back to the top


Antibiotic resistance: Zeocin®blasticidin

Growth Medium: DMEM, 4.5 g/l glucose, 2 mM L-glutamine, 10% (v/v) fetal bovine serum (FBS), 100 U/ml penicillin, 100 µg/ml streptomycin, 100 µg/ml Normocin™

Test Medium for use with QUANTI-Blue™: DMEM, 4.5 g/l glucose, 2 mM L-glutamine, 10% (v/v) heat-inactivated FBS (30 min at 56°C), 100 U/ml penicillin, 100 µg/ml streptomycin

Quality control:

  • RIG-I knockout has been verified by functional assays and DNA sequencing.
  • The stability of this cell line for 20 passages following thawing has been verified.
  • A549-DualKO-RIG-I cells are guaranteed mycoplasma-free.


This product is covered by a Limited Use License (See Terms and Conditions).

Back to the top


Shipped on dry ice Shipped on dry ice (Europe, USA, Canada, and some areas in Asia)

Back to the top


RIG-I (retinoic-acid-inducible protein 1, also known as Ddx58) is a cytoplasmic RNA helicase that is critical for host antiviral responses. It senses double-stranded RNA (dsRNA), a replication intermediate for RNA viruses, leading to production of type I interferons (IFNs). Notably, it binds specifically to short dsRNAs that have blunt ends and a 5′ triphosphate (5′-ppp) moiety, facilitating discrimination between host and viral dsRNA. RIG-I and the related RNA helicase MDA-5 recognize a complementary set of cytosolic viral dsRNA. Interestingly, transfected poly(I:C), a synthetic analog of viral dsRNA, is recognized by both RIG-I and MDA-5.

A549-Dual KO RIG-I pathway

Back to the top

FAQ Cell Lines

Visit our FAQ Any questions about our cell lines ? Visit our frequently asked questions page

Back to the top

Notification:  This product is for internal research use only. Additional rights may be available. Please visit InvivoGen’s Terms and Conditions.

Customer Service
& Technical Support
Shopping cart is empty